CompletedNCT02124395

Health-related Quality of Life in Rare Kidney Stone

Studying Primary hyperoxaluria

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: NYU Langone Health
Principal Investigator: David Goldfarb, MD, M.D
NYU Langone Health
Intervention: Health-related Quality of Life in Rare Kidney Stone Questionnaire(other)
Enrollment: 365 enrolled
Eligibility: 5 years · All sexes
Timeline: 2013 – 2022

Study locations (3)

Primary Hyperoxaluria and Dent Disease Registry - Mayo Clinic, Rochester, Minnesota, United States
New York University School of Medicine - Cystinuria Registry, New York, New York, United States
APRT Registry - Landspitali Universtiy Hospital, Reykjavik, Iceland

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02124395 on ClinicalTrials.gov

Other trials for Primary hyperoxaluria

Additional recruiting or active studies for the same condition.

See all trials for Primary hyperoxaluria →

← Back to all trials